About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Evaluating a Novel Medication Device for Methadone Dosing

NCT03254043·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Johns Hopkins University

With

National Institute on Drug Abuse (NIDA)

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

18 years or older
Receiving methadone for the treatment of opioid use disorder for at least 90 days and having been on the same methadone dose for at least 30 days
Have previously received a take-home dose of methadone as part of routine care
Be willing to comply with the study schedule
Be a methadone patient in the clinic within which this study is being conducted

You may not be if

Pregnancy
Presence of an acute medical problems that requires immediate or intense medical management
Presence of serious or unstable mental illness that interferes with study procedures
Planning to leave methadone treatment within the next 12 weeks
Being maintained on a dose of methadone that is less than 10mg or more than 100mg
Currently receiving split doses of methadone as part of routine care

The record

StatusCompleted

PhaseNo phase

Taking part26

StartedJan 2018

UpdatedSep 28, 2020

Conditions

Opioid-use Disorder

Where1

Addiction Treatment Services (ATS)
Baltimore, Maryland, United States

Clareo Health | Evaluating a Novel Medication Device for Methadone Dosing